TABLE 3.
MiRNA Enrichment Analysis Results for Three K-Mean Clusters
| Cluster | Category | Subcategory | N | Observed miRNAs | P (FDR) |
| 1 | Organs | Stem Cells | 8 | miR-126-3p; miR-133b; miR-15a-5p; miR-195-5p; miR-29b-3p; miR-302a-3p; miR-302b-3p; miR-326 | 0.048 |
| Pathways | Inflammation mediated by chemokine and cytokine signaling (P00031) | 19 | miR-126-3p; miR-135a-5p; miR-15a-5p; miR-193b-3p; miR-195-5p; miR-196b-5p; miR-218-5p; miR-22-3p; miR-29b-3p; miR-302a-3p; miR-302b-3p; miR-30e-3p; miR-320c; miR-326; miR-337-3p; miR-451a; miR-7-5p; miR-935; miR-96-5p | 0.048 | |
| Cytokine–cytokine receptor interaction (hsa04060) | 9 | miR-126-3p; miR-133b; miR-15a-5p; miR-193b-3p; miR-195-5p; miR-22-3p; miR-29b-3p; miR-302b-3p; miR-7-5p | 0.048 | ||
| Cell adhesion molecules (hsa04514) | 6 | miR-126-3p; miR-15a-5p; miR-193b-3p; miR-196b-5p; miR-218-5p; miR-29b-3p | 0.048 | ||
| 2 | Organs | Stem cells | 6 | miR-137; miR-138-5p; miR-214-3p; miR-224-5p; miR-27a-3p; miR-302d-3p | 0.021 |
| 3 | Diseases | Burkitt lymphoma | 2 | let-7a-5p; let-7b-5p | 0.033 |
| Carcinoma | 19 | let-7a-5p; let-7b-5p; let-7c-5p; miR-106b-5p; miR-1226-3p; miR-125a-5p; miR-141-3p; miR-145-5p; miR-151a-5p; miR-181a-5p; miR-181c-5p; miR-185-5p; miR-197-3p; miR-19a-3p; miR-19b-3p; miR-21-5p; miR-223-3p; miR-376b-3p; miR-93-5p | 0.033 | ||
| Melanoma | 2 | let-7a-5p; let-7b-5p | 0.033 | ||
| Target genes | AIDA | 3 | let-7a-5p; let-7b-5p; let-7c-5p | 0.019 | |
| ANKRD17 | 3 | let-7a-5p; let-7b-5p; let-7c-5p | 0.019 | ||
| CCNB2 | 3 | let-7a-5p; let-7b-5p; let-7c-5p | 0.019 | ||
| CSNK2A1 | 3 | let-7a-5p; let-7b-5p; let-7c-5p | 0.019 | ||
| DHX9 | 3 | let-7a-5p; let-7b-5p; let-7c-5p | 0.019 | ||
| IPO7 | 5 | let-7a-5p; let-7b-5p; let-7c-5p; miR-106b-5p; miR-1226-3p | 0.010 | ||
| LTA4H | 3 | let-7a-5p; let-7b-5p; let-7c-5p | 0.019 | ||
| NME4 | 3 | let-7a-5p; let-7b-5p; let-7c-5p | 0.019 | ||
| PTGES2 | 3 | let-7a-5p; let-7b-5p; let-7c-5p | 0.019 | ||
| RPS24 | 3 | let-7a-5p; let-7b-5p; let-7c-5p | 0.019 |